Formulation and evaluation of sustained release floating tablets of venlafaxine using natural polymers
Abstract
Over the past three decades, oral controlled-release dosage forms have been developed due to their therapeutic advantages, such as ease of administration, patient compliance, and flexibility in formulation. However, this approach has faced physiological difficulties, such as the inability to contain and position the controlled drug delivery system within the desired region of the gastrointestinal tract (GIT) due to variable gastric emptying and motility. Venlafaxine is an antidepressant and a serotonin and norepinephrine reuptake inhibitor (SNRI). Its active metabolite, desvenlafaxine, works by blocking the reuptake of serotonin and norepinephrine, which are key neurotransmitters in mood regulation. Gastroretentive dosage forms can stay in the gastric region for several hours and significantly prolong the gastric residence time of drugs. Natural materials have been extensively used in drug delivery because they are readily available, cost-effective, eco-friendly, capable of many chemical modifications, potentially degradable, and compatible due to their natural origin.
Keywords: Sustained Release Floating Tablets, Venlafaxine,
Keywords:
Sustained Release, Floating Tablets, VenlafaxineDOI
https://doi.org/10.22270/jddt.v14i6.6611References
Singh B.N. and Kim K.H., Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J Control Release, 2000; 63: 235-259. https://doi.org/10.1016/S0168-3659(99)00204-7 PMid:10601721
Streubel A, Siepmann J, Bodmeier R. Gastroretentive drug delivery system. Expert Opin Drug Deliv. 2006; 3 (2): 217-233. https://doi.org/10.1517/17425247.3.2.217 PMid:16506949
Dhakar RC, Maurya SD, Aggarwal S, Kumar G, Tilak VK, Design and evaluation of SRM microspheres of metformin hydrochloride, Pharmacie Globale (IJCP), 2010;1(07);
Kawashima, Y., Niwa, T., Takeuchi, H., Hino, T., and Ito, Y. Preparation of multiple unit hollow microspheres (micro ballons) with acrylic resin containing tranilast and their drug release characteristics (in vitro) and floating behavior (in vivo). J. Control. Rel. 1991;16: 279-290. https://doi.org/10.1016/0168-3659(91)90004-W
Gharti KP, Budhathoki U, Thapa P, Bhargava A. Formulation in vitro evaluation of floating tablets of hydroxypropyl methylcellulose and polyethylene oxide using ranitidine hydrochloride as a model drug. Journal of Young Pharmacists. 2012 Oct 1;4(4):201-8. https://doi.org/10.4103/0975-1483.104363 PMid:23493037 PMCid:PMC3573371
Fu J, Yin H, Yu X, Xie C, Jiang H, Jin Y, Sheng F. Combination of 3D printing technologies and compressed tablets for preparation of riboflavin floating tablet-in-device (TiD) systems. International journal of pharmaceutics. 2018 Oct 5;549(1-2):370-9. https://doi.org/10.1016/j.ijpharm.2018.08.011 PMid:30107218
Patel VF, Patel NM, Yeole PG. Studies on formulation and evaluation of ranitidine floating tablets. Indian journal of pharmaceutical sciences. 2005;67(6):703.
Garg R, Gupta GD. Progress in controlled gastroretentive delivery systems.Trop. J Pharm Res 2008; 7(3): 1055-66. https://doi.org/10.4314/tjpr.v7i3.14691
Lin X, Fu H, Hou Z, Si Y, Shan W, Yang Y. Three-dimensional printing of gastro-floating tablets using polyethylene glycol diacrylate-based photocurable printing material. International Journal of Pharmaceutics. 2021; 15; 603:120674. https://doi.org/10.1016/j.ijpharm.2021.120674 PMid:33964341
Rouge N, Buri P, Voelker E. Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery. Int J Pharma. 1996; 136:117-139. https://doi.org/10.1016/0378-5173(96)85200-8
Emara LH, Abdou AR, El-Ashmawy AA, Mursi NM. Preparation and evaluation of metronidazole sustained release floating tablets. Int J Pharm Pharm Sci. 2014;6(9):198-204.
Kumar PD, Rathnam G, Prakash CR, Saravanan G, Karthick V, Selvam TP. Formulation and characterization of bilayer floating tablets of ranitidine. Rasayan J. Chem. 2010;3(2):368-74.
Published
Abstract Display: 177 
PDF Downloads: 122 PDF Downloads: 64 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.